hydration effects glp-1 receptor agonist therapy 2025 Nutritional priorities to support for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society The dual impact of GLP-1

Assessment of the reasons for the mismatch between the results of CV outcomes trials with GLP-1RAs and DPP-4 inhibitors remains a challenge

A Predictive Mathematical Modeling Approach for the Study of Doxorubicin Treatment in Triple Negative Breast Cancer

Wirkungen auf das Haar: GHK-Cu hat auch positive Effekte auf die Haarfollikel gezeigt

Mairuae N, Cheepsunthorn P, Buranrat B

Graphical Abstract Keywords Metabolic dysfunction-associated steatotic liver disease, Glucagon-like peptide-1 receptor agonist, Clinical trial, Treatment, Metabolic dysfunction-associated steatohepatitis, Fibrosis Introduction Nonalcoholic fatty liver disease has been used to describe hepatic steatosis without significant alcohol intake